Peptide Certificates of Analysis: What a COA Can and Cannot Show
A certificate of analysis describes particular testing of a particular sample. It does not establish clinical effectiveness, a safe human dose, FDA approval, or that every product bearing a similar name matches the tested material.
By PacificRx editorial team · Published
At a glance
A certificate of analysis describes particular testing of a particular sample. It does not establish clinical effectiveness, a safe human dose, FDA approval, or that every product bearing a similar name matches the tested material. Evaluate laboratory documentation separately from clinical and prescribing evidence.
- Match the certificate to the actual lot and sample.
- Check what the test did and did not measure.
- Laboratory findings are not proof of patient benefit.
On this page
What does a COA describe?
A certificate may identify a sample, lot, test method, date, and reported findings. Those details determine what the document can tell you. A result without a clear connection to the supplied product is difficult to interpret.
Ask who performed the testing, what material was sampled, and which tests were included. A screenshot of a percentage, without the rest of the report or an identifiable sample, leaves important questions unanswered.
Does a purity number prove safety?
A purity result is not a complete account of a product's suitability for patient use. Product identity, formulation, handling, contamination risks, labeling, and clinical context remain separate questions.
The FDA explains that compounded drugs do not undergo its premarket review for safety, effectiveness, or quality. A laboratory certificate does not turn a compounded or research-only product into an FDA-approved medicine.
Does testing establish that a peptide works?
Clinical benefit requires evidence in an appropriate human population for a specific substance, formulation, and intended use. Testing a sample in a laboratory cannot supply that evidence.
Likewise, a result from one peptide does not establish a benefit for another. Treat a laboratory document, an animal study, and a clinical trial as different forms of information rather than interchangeable endorsements.
Which questions belong with a clinician or pharmacist?
Ask about the exact prescribed substance, its evidence and regulatory status, why it is being considered, and who dispenses it. Bring a certificate as one document in that conversation, not as a substitute for the conversation.
If a seller uses a COA to claim that an experimental compound is universally safe or proven, ask for the clinical basis of that claim. Do not turn a product-testing percentage into a personal administration plan.